The Purpose of the Study is to Compare Two Fixed Dose Combination Tablets of Dapagliflozin/Metformin XR in Healthy Subjects Under Fasting and Fed Conditions

Status:
Completed

Trial end date:
2018-05-22

Target enrollment:

Participant gender:

This is a bioequivalence study of two doses of the dapagliflozin/metformin XR tablet manufactured at two different plants.

Phase 1

AstraZeneca

Dapagliflozin
Metformin